The science of toxicology is undergoing a revolutionary change. For decades, we have been relying on the following factors to assess safety of health and consumer products and of chemicals in general: 1. Animal Testing in Laboratories. 2. Descriptive readouts explaining the side effects.
There have been serious doubts over the limited experimental support and relevance of current methodologies and the value of preclinical in vivo testing which is marred with various uncertain factors.
Today, we enter in another era of understanding and modelling the mechanisms of toxicity with in vitro and computational systems for predicting the effects of drugs, chemicals, healthcare and consumer products on human beings. While the Regulatory authorities governing the market entry authorization of these products, are making AOP ((adverse outcome pathway) and NAM (new approach method) concepts the foundations of the future Test Guidelines The business of the predictive toxicology is also changing rapidly with many mergers, acquisitions and entrance of new players on the market complying to new age technology and building up scale of business. The final motive is acquiring and gathering new skills required to counter these changes and being able to anticipate the growth of segments in certain markets and the decline in others.
Wepredic has been created as an umbrella organization to the two experienced and long standing market leading companies Biopredic International and Eurosafe and adding two new ventures namely, Starlight and Biopredic Advancells, for covering the entire domain of in vitro assay kits aimed at taking over the animal experimentation market.
While Biopredic International and Biopredic Advancells will focus on production of human cell systems, Starlight will focus on synthetizing chemicals for imaging key proteins involved in toxicity pathways and Eurosafe will continue to perform key services and operates as a CRO (contract research organization) thus providing full coverage of the companies domain of assays.
Wepredic has a global footprint with branches in Europe, America and India and distributors in Asia and has in depth knowledge of the customer practices in matter of drug and cosmetic developments and regulatory challenges, Wepredic is ready for the exciting challenges of the reshaped toxicology for a safer world.